An optimization approach to prescribed burning for mitigating PM2.5 emissions in wildfire management
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Strategic prescribed burning significantly cuts wildfire risks and costs. Optimizing its extent minimizes fine particulate matter (PM2.5) health impacts and reduces net fire costs by over 25%.
Area Of Science
- Environmental Science
- Forestry
- Public Health
Background
- Prescribed burning manages forest fuels but generates PM2.5 emissions, posing health risks.
- Balancing wildfire hazard reduction with PM2.5 impacts is crucial for effective forest management.
Purpose Of The Study
- To analyze the impact of prescribed burning PM2.5 emissions on total net costs.
- To develop an optimization model for strategic prescribed burning to minimize emission costs.
Main Methods
- Developed an optimization model quantifying prescribed burning implementation and PM2.5 social costs.
- Applied the model to Oregon in 2021, analyzing prescribed burning extent and emission impacts.
Main Results
- Prescribed burning reduced wildfire emissions and social costs by 65.30% with a benefit-cost ratio of 4.35.
- Optimal prescribed burning extent reduced total net costs by 25.68%, requiring a 15.65% acreage increase.
- Over-implementation of prescribed burning increased net costs due to elevated PM2.5 social costs and adverse health outcomes.
Conclusions
- Prescribed burning strategies significantly influence PM2.5 emissions.
- Integrating emission assessments into fire management planning is critical for minimizing adverse health and environmental impacts.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Flame photometry, also known as flame emission spectrometry, is a technique used for the qualitative and quantitative analysis of elements present in a sample using a flame as the source of excitation energy. The concept of flame photometry was realized in the early 1860s by Kirchhoff and Bunsen, who discovered that specific elements emit characteristic radiation when excited in flames. The first instrument developed for this purpose was used to measure sodium (Na) in plant ash using a Bunsen...
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...